Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.

doi:10.1002/gcc.22542

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.

Genes, chromosomes & cancer - 1 Aug 2018

Terada Kazuki, Yamaguchi Hiroki, Ueki Toshimitsu, Usuki Kensuke, Kobayashi Yutaka, Tajika Kenji, Gomi Seiji, Kurosawa Saiko, Saito Riho, Furuta Yutaka, Miyadera Keiki, Tokura Taichiro, Marumo Atsushi, Omori Ikuko, Sakaguchi Masahiro, Fujiwara Yusuke, Yui Shunsuke, Ryotokuji Takeshi, Arai Kunihito, Kitano Tomoaki, Wakita Satoshi, Fukuda Takahiro, Inokuchi Koiti

Abstract excerpt

BCOR gene is a transcription regulatory factor that plays an essential role in normal hematopoiesis. The wider introduction of next-generation sequencing technology has led to reports in recent years of mutations in the BCOR gene in acute myeloid leukemia (AML), but the related clinical characteristics and prognosis are not sufficiently understood. We investigated the clinical characteristics and prognosis of 377...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytogenetic Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fms-Like Tyrosine Kinase 3

Share to High-Throughput Nucleotide Sequencing

Share to Leukemia, Myeloid, Acute

Share to Prognosis

Share to Proto-Oncogene Proteins

Share to Repressor Proteins

Share to Survival Rate

Source

Open in PubMed

Identifiers

PMID: 29663558
DOI: 10.1002/gcc.22542

Genes

BCOR
BCORL1
FLT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.PMID 29663558Read ↗

The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study.Semantic proximity Read ↗

Features and impacts on the prognosis of gene mutations in patients with acute myeloid leukemia.Semantic proximity Read ↗

[Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes].Semantic proximity Read ↗

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.Semantic proximity Read ↗

The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemiaSemantic proximity Read ↗

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeSemantic proximity Read ↗

Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms.Semantic proximity Read ↗

Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia.Semantic proximity Read ↗

Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis.Semantic proximity Read ↗

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.Semantic proximity Read ↗

Prognosis and outcome of patients with acute myeloid leukemia based on FLT3‑ITD mutation with or without additional abnormal cytogeneticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.